IPP Bureau
U.S. FDA allows Pfizer and Moderna booster doses for all
By IPP Bureau - November 20, 2021
This is a shot in the arm for the vaccine manufacturers
Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn
By IPP Bureau - November 20, 2021
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
U.S. FDA approves first drug to improve growth in kids with most common form of dwarfism
By IPP Bureau - November 20, 2021
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Natco launches Tipanat tablets in India
By IPP Bureau - November 19, 2021
It is used for the treatment of advanced colorectal and gastric cancer
CIMS multi super specialty hospital performs 150 bone marrow transplants
By IPP Bureau - November 19, 2021
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
PM Modi hails pharma industry for its innovation
By IPP Bureau - November 19, 2021
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
Novavax and Serum Institute receive EUA for Covovax
By IPP Bureau - November 18, 2021
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
Illumina and Sequoia Capital China selects startups for Genomics
By IPP Bureau - November 18, 2021
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Zydus Cadila receives U.S.FDA approval for leukaemia injection
By IPP Bureau - November 18, 2021
Nelarabine is in a class of medications called antimetabolites
Daiichi Sankyo initiates Phase 2 trial of mRNA Covid-19 vaccine in Japan
By IPP Bureau - November 18, 2021
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
Roche launches cobas 5800, a new molecular diagnostics system
By IPP Bureau - November 18, 2021
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
US govt signs deal with GSK and Vir Biotechnology to buy sotrovimab, a Covid-19 treatment
By IPP Bureau - November 18, 2021
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
AstraZeneca’s Covid-19 drug offers 83% protection over six months
By IPP Bureau - November 18, 2021
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
Sluggish exports to cap pharma revenue growth at 9% this fiscal
By IPP Bureau - November 17, 2021
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Private equity firm Carlyle partners with Viyash Life Sciences for pharma platform
By IPP Bureau - November 17, 2021
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
